Regeneron Pharmaceuticals, Inc.
REGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000872589
In the last 90 days, Regeneron Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 11 sales; 1,348 institutions reported holding it in 13F filings for Q2 2026, worth $57.1B in total; Southeastern Asset Management (Longleaf) is the only superinvestor holding it.
Key figures
- Market capNo recent share count in SEC filings
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $51.9M in total
- 11
- 13F holdersQ2 2026, −44 vs. previous quarter
- 1,348
- 13F valueReported value at the end of Q2 2026
- $57.1B
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $14.3B
- +1.0% year over year
- Net income, FY2025
- $4.50B
- +2.1% year over year
- Free cash flow, FY2025
- $4.08B
- +11.3% year over year
- Revenue, Q3 FY2026
- $5.12B
- +36.3% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 2.22M
- Shares sold short
- Change
- +82.2K
- +3.9% vs. previous
- Days to cover
- 2.73
- At average daily volume
Superinvestors holding REGN, Q2 2026
Go to the superinvestors tab1 superinvestor reports holding Regeneron Pharmaceuticals, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Southeastern Asset Management (Longleaf)
Mason Hawkins
5.0%
Regeneron Pharmaceuticals, Inc.'s share of the portfolio
- Shares
- 152,322
- Value
- $95.0M
Latest insider trades
See all insider tradesOpen-market purchases and sales by Regeneron Pharmaceuticals, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2026 (view filing)4:01 PM ET | Nov 4 | 2 days | Pitofsky JasonSVP Controller | SSale | −3.88K | $941.79 | −$3.66M | −47.6%4.27K after | 7 lots |
| Nov 6, 2026 (view filing)4:01 PM ET | Nov 4 | 2 days | Pitofsky JasonSVP Controller | SSale | −179 | $950.76 | −$170.2K | −100.0%0 after | |
| Nov 5, 2026 (view filing)4:05 PM ET | Nov 3 | 2 days | Zoghbi Huda YDirector | SSale | −7.44K | $970.46 | −$7.22M | −81.4%1.70K after | 2 lots |
| Nov 4, 2026 (view filing)4:11 PM ET | Nov 2 | 2 days | Sing George LDirector | SSale | −21.1K | $964.38 | −$20.4M | −45.7%25.1K after | 9 lots |
| Nov 4, 2026 (view filing)4:09 PM ET | Nov 2 | 2 days | Poon Christine ADirector | SSale | −7.83K | $969.09 | −$7.59M | −60.0%5.22K after | 6 lots |
| Nov 4, 2026 (view filing)4:04 PM ET | Nov 2 | 2 days | Larosa Joseph JEVP General Counsel and Secret | SSale | −4.47K | $965.49 | −$4.31M | −10.3%38.9K after | 2 lots |
| Nov 3, 2026 (view filing)4:22 PM ET | Oct 30 | 4 days | Guarini KathrynDirector | SSale | −400 | $900.00 | −$360.0K | −39.9%603 after | 10b5-1 |
| Nov 3, 2026 (view filing)4:05 PM ET | Oct 30 | 4 days | Brown Michael SDirector | SSale | −1.93K | $875.00 | −$1.69M | −58.3%1.38K after | 10b5-1 |
| Nov 3, 2026 (view filing)4:02 PM ET | Oct 30 | 4 days | McCourt MarionEVP Commercial | SSale | −1.13K | $869.43 | −$984.2K | −9.4%10.9K after | 10b5-1 |
| Oct 15, 2026 (view filing)4:02 PM ET | Oct 14 | 1 day | Murphy Andrew JCo-Chief Scientific Officer | SSale | −4.15K | $772.70 | −$3.20M | −8.0%47.8K after | 27 lots10b5-1 |
Top 10 13F holders, Q2 2026
See all 1,348 holdersThe largest institutional positions in Regeneron Pharmaceuticals, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9,113,506 | $5.68B | 0.08% | +165,771+1.9% | Added |
| Vanguard Capital Management LLC | 6,629,759 | $4.13B | 0.09% | −25,154−0.4% | Reduced |
| Dodge & Cox | 4,871,137 | $3.04B | 1.59% | +412,899+9.3% | Added |
| State Street Corp | 4,834,688 | $3.01B | 0.09% | +170,210+3.6% | Added |
| Invesco Ltd. | 3,940,665 | $2.46B | 0.19% | +35,556+0.9% | Added |
| JPMorgan Chase & Co | 3,774,199 | $2.38B | 0.14% | −537,607−12.5% | Reduced |
| Vanguard Portfolio Management LLC | 3,175,313 | $1.98B | 0.09% | +1,454,539+84.5% | Added |
| Franklin Resources Inc | 2,771,839 | $1.73B | 0.37% | +49,768+1.8% | Added |
| Geode Capital Management, LLC | 2,625,810 | $1.63B | 0.09% | +18,078+0.7% | Added |
| Nuveen, LLC | 2,019,974 | $1.26B | 0.30% | −45,090−2.2% | Reduced |
Holders of 5% or more of REGN
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Regeneron Pharmaceuticals, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 13G | 7.37%7.66M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |
Politician trades
All politician trades in REGN15 members of Congress reported 60 trades in Regeneron Pharmaceuticals, Inc. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Jul 21, 2026 |  Alan Armstrong Senate · OK | Buy | $1K-$15K |
| Jun 8, 2026 |  Gilbert Ray Cisneros, Jr. House · CA | Sell | $1K-$15K |
| Mar 12, 2026 |  Julia Letlow House · LA | Buy | $1K-$15K |
| Dec 15, 2025 | Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
| Jun 9, 2025 |  Robert P. Bresnahan, Jr. House · PA | Buy | $1K-$15K |
Senate · OK · Jul 21, 2026
Buy$1K-$15K
House · CA · Jun 8, 2026
Sell$1K-$15K
House · LA · Mar 12, 2026
Buy$1K-$15K
House · CA · Dec 15, 2025
Buy$1K-$15K
House · PA · Jun 9, 2025
Buy$1K-$15K